SCHEMBL23569602

SCHEMBL23569602

c1ccc(-c2cccc(-n3c4ccccc4c4cc5c6ccccc6n(-c6ccc7ccc(-c8cc(-c9ccccc9)nc(-c9ccccc9)n8)cc7c6)c5cc43)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.39
MEN1 O00255 6/20 0.39
MAPT P10636 6/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 5/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 2/20 0.39
GLA P06280 1/20 0.39
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
NTSR1 P30989 1/20 0.37
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23569610 0.97 KDM4E (0.37) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23569143 0.96 KDM4E (0.39) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL22595972 0.96 KDM4E (0.41) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23569648 0.95 KDM4E (0.38) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23568892 0.94 KDM4E (0.42) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL22596076 0.93 MEN1 (0.44) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23569172 0.93 MEN1 (0.38) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23569607 0.92 KDM4E (0.39) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23569692 0.92 KDM4E (0.42) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL23568828 0.92 CYP1A1 (0.46) KMT2AMEN1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210193931-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2021-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210193931-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE TERT, ICOSLG, ELAVL1 KMT2A 1278/4885MEN1 1948/4885MAPT 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.